Wanzai's Polls

A Look Back: Abandoned Painkiller Makes a Comeback

On Thursday, the FDA said it wants the oxymorphone product Opana ER removed from the market, capping years of controversy over the opioid painkiller. MedPage Today and the Milwaukee Journal Sentinel in 2015 published an investigation of how the FDA came to approve Opana ER and what had gone wrong. Here we republish that investigation to provide context for the recent FDA action. In 2006, in the mi
Show Results  |  Share  |  Report  |  0 votes  |  51 views